Study uncovers 23 new genetic markers linked to kidney health on the X-chromosome

A meta-analysis of 908,697 samples to investigate the genetic, sex-dependent basis of kidney traits.

FILAMENT HEALTH ANNOUNCES UPSIZING AND CLOSING OF $2,500,000 NON-BROKERED PRIVATE PLACEMENT FINANCING – Psychedelic Alpha

Financing led by psychedelic investment fund Negev Capital VANCOUVER, BC, July 24, 2023 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or

July 24, 2023

AlidaBio Secures $7.5M to Optimize Epitranscriptomic Research

What You Should Know: – Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, proudly announces the successful completion of a $7.5 million Series A

June 12, 2024

Psyence Biomedical Ltd. Provides Update on Upcoming Phase IIb Trial | Psychedelic Invest

Psyence Biomedical Ltd. announced the export of nature-derived psilocybin to Australia and provided an update on its upcoming Phase IIb clinical trial evaluating nature-derived psilocybin

July 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.